BIOTON S.A. (WSE:BIO)
4.410
-0.050 (-1.12%)
Oct 3, 2025, 5:00 PM CET
BIOTON Revenue
BIOTON had revenue of 79.85M PLN in the quarter ending June 30, 2025, with 57.78% growth. This brings the company's revenue in the last twelve months to 265.14M, up 42.31% year-over-year. In the year 2024, BIOTON had annual revenue of 207.76M with 14.38% growth.
Revenue (ttm)
265.14M
Revenue Growth
+42.31%
P/S Ratio
1.43
Revenue / Employee
730.41K
Employees
364
Market Cap
378.66M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 207.76M | 26.13M | 14.38% |
Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
Dec 31, 2020 | 221.79M | 19.76M | 9.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Diagnostyka | 2.17B |
NEUCA | 13.04B |
Synektik Spólka Akcyjna | 623.20M |
Voxel | 560.38M |
Celon Pharma | 206.22M |
Selvita | 373.90M |
Centrum Medyczne ENEL-MED | 789.78M |
Ryvu Therapeutics | 130.10M |